UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042626
Receipt number R000048545
Scientific Title An exploratory study of the Mindfulness App for Weight loss in metabolic syndrome
Date of disclosure of the study information 2021/03/31
Last modified on 2023/03/30 16:35:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An exploratory study of the Mindfulness App for Weight loss in metabolic syndrome

Acronym

MATWLstudy

Scientific Title

An exploratory study of the Mindfulness App for Weight loss in metabolic syndrome

Scientific Title:Acronym

MATWLstudy

Region

Japan


Condition

Condition

Metabolic syndrome

Classification by specialty

Medicine in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine whether the use of a mindfulness app in conjunction with traditional diet and exercise-based health class, compared to traditional diet and exercise-based health class, has sustained long-term weight loss effect.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The difference in weight change at 3 and 6 months after the intervention.
The analysis includes ITT and Per protocol analysis, which specifies that the intervention group is defined as those who use the application more than 5 times per week on average, based on the application's log records.

Key secondary outcomes

Changes in abdominal circumference, body composition (body mass index, body fat percentage, and muscle mass), systolic blood pressure change, diastolic blood pressure change, HDL change, LDL change, HbA1c change, and the results of the questionnaire survey (DEBQ, Motivation to Eat Healthy Scale, IPAQ Japanese version, Behavioral Change Stage Model) at 3 and 6 months.
The analysis includes ITT and Per protocol analysis, which specifies that the intervention group is defined as those who use the application more than 5 times per week on average, based on the application's log records.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

Participation in a 3-month diet and exercise therapy health class.
In addition to the above, practice daily mobile app mindfulness for 3 months.
From month 4 to month 6 after the start of the study, check lifestyle by phone every 1 month.

Interventions/Control_2

Participation in a 3-month diet and exercise therapy health class.
From month 4 to month 6 after the start of the study, check lifestyle by phone every 1 month.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients who underwent physical checkup at the Kasugai general health care center in 2020, and with one or more risk factors of the international diabetes federation (IDF) for metabolic syndrome.

Waist circumference: Male 90 cm or more, female 80 cm or more.
One or more of the following items (1) to (4).
(1)Fasting blood glucose 100 mg/dL or more or a history of type 2 diabetes.
(2) Blood pressure 130/85 mmHg or on treatment.
(3) Triglycerides 150 mg/dl or more.
(4) HDL cholesterol: less than 40 mg/dl in men, less than 50 mg/dl in women, or on treatment.

Key exclusion criteria

Patients with a history of serious cardiac disease or other medical conditions, and who are prohibited by their physicians from exercising, etc.
Severe depression, severe anxiety disorder, severe somatoform disorder, psychotic symptoms, those with a history of these, or those who are currently in the hospital.
Those who do not have a cell phone that can use mobile applications.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Takaharu
Middle name
Last name Matsuhisa

Organization

Nagoya university hospital

Division name

Department of general medicine

Zip code

466-8560

Address

65 Tsurumai-cho,Showa-ku,Nagoya

TEL

052-744-2951

Email

matsukyuu413@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Takaharu
Middle name
Last name Matsuhisa

Organization

Nagoya university hospital

Division name

Department of general medicine

Zip code

466-8560

Address

65 Tsurumai-cho,Showa-ku,Nagoya

TEL

052-744-2951

Homepage URL


Email

matsukyuu413@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya university graduate school of medicine

Institute

Department

Personal name



Funding Source

Organization

JSPS KAKENHI

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Kasugai general health care center

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya university hospital

Address

65 Tsurumai-cho,Showa-ku,Nagoya

Tel

052-744-2951

Email

ethics@med.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

名古屋大学医学部附属病院(愛知県)、春日井市総合保健医療センター(愛知県)


Other administrative information

Date of disclosure of the study information

2021 Year 03 Month 31 Day


Related information

URL releasing protocol

https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000048545

Publication of results

Published


Result

URL related to results and publications

https://link.springer.com/article/10.1007/s12529-023-10173-2

Number of participants that the trial has enrolled

32

Results

Eight of the 40 participants declined to participate. The MMA was used average 4.4 days per week, but the rate of adherence declined over time. The follow-up rate was 100%, and there was no difference in participant satisfaction between the groups. There was no significant group-by-time interaction for weight loss (p = 0.924), but there was a significant interaction for the DEBQ restrained eating score (p = 0.033).

Results date posted

2023 Year 03 Month 30 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Eligibility criteria were used to select adults aged 20-75 years with MetS, as defined by the international diabetes federation (IDF) that had smartphones with mobile applications available. The exclusion criteria were a history of serious heart disease or other conditions that prohibited exercise therapy, severe depression, severe anxiety disorder, severe somatoform disorder, and psychotic symptoms. We recruited 1031 participants (663 females) by mail who met the eligibility criteria from among individuals who underwent physical examinations at a general healthcare center in Kasugai City, Japan. Participants were recruited from April 2020 to January 2021. Three evaluation sessions (baseline, week 13, and week 26) were conducted at the general healthcare center.

Participant flow

This open-label, parallel, pilot RCT included a 13week CLI, which comprised a supportive workshop after a physical examination at a city general health center plus telephone counseling every 4 weeks for the following 13 weeks with and without MMA use. The application was provided to all participants, but the provision period was divided into two phases: 1-26 weeks and 27-52 weeks. We compared data between the two groups over 26 weeks. Participants were stratified by sex and randomly assigned to the two groups using a 1:1 ratio. After allocation, participants underwent baseline assessment, and those who did not meet the eligibility criteria were excluded from the analyses. The intervention was provided free of charge. This pilot trial was not designed to have sufficient statistical power to assess the effectiveness of the MMA intervention on weight loss and eating behavior.

Adverse events

nothing

Outcome measures

Acceptability, adherence, and feasibility were measured by the number of people who refused to consent to the study after receiving orientation, the rate of adherence to the application (number of days application implementation was completed), follow up rate, participant satisfaction, and number of adverse events. The primary outcome of using the MMA was the rate of change in body weight. Body weight was measured in units of 0.1 kg, while wearing test clothes. Secondary outcome measures was eating behavior, the modified Japanese version of the Dutch Eating Behavior Questionnaire (DEBQ) was used to evaluate eating behavior.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 02 Month 05 Day

Date of IRB

2021 Year 03 Month 22 Day

Anticipated trial start date

2021 Year 04 Month 01 Day

Last follow-up date

2021 Year 11 Month 01 Day

Date of closure to data entry

2021 Year 11 Month 01 Day

Date trial data considered complete

2021 Year 11 Month 01 Day

Date analysis concluded

2021 Year 11 Month 15 Day


Other

Other related information



Management information

Registered date

2020 Year 12 Month 02 Day

Last modified on

2023 Year 03 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048545


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name